Study in Nature outlines how in vitro and in vivo (mouse model), specific white blood cells (B-Cells) can be genetically programmed to produce anti-HIV antibodies thus offer a one-time treatment for the disease. Long way to go but elegant study design.

Medical Mythbusting Commentary for June 15, 2022

A “One-Time” Treatment for HIV Could Be on the Horizon

In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice